Safety, quality & education

Clinical benefit of Artificial Intelligence (AI)-assisted lung ultrasound in a resource-limited intensive care unit

Crit CarePublished Prospective study

Authors' conclusion

AI-assisted LUS can help non-expert clinicians in an LMIC ICU improve their performance in interpreting LUS features more accurately, more quickly and more confidently.

Study context

Population
Clinicians interpreting point-of-care lung ultrasound (LUS) in a low-resource LMIC intensive care unit (ICU)
Exposure
Non-expert clinicians interpreting LUS with vs without a bespoke AI tool
Outcome
Accuracy of LUS interpretation, prospective real-time testing in ICU
Methodological detailsthree-phase
  • Three-phase

Main finding

As reported in the abstract

P < 0.001

Observational data: associations, not effects.

Further findings

Time-to-interpret clips

P < 0.001

OutcomeWith AI toolWithout AI toolP value
LUS interpretation accuracy by clinical user group (first phase)Experts vs Beginners, Intermediate, Advanced · experts significantly betterP < 0.001
LUS interpretation accuracy, prospective real-time testing in the ICU (non-expert clinicians)93.4% (95% CI 89.0–97.8%)68.1% (95% CI 57.9–78.2%)P < 0.001
Clinicians' confidence levelmedian 4 out of 4median 3 out of 4
  • LUS interpretation accuracy by clinical user group (first phase): Beginners average 68.7% (95% CI 66.8–70.7%)
  • LUS interpretation accuracy by clinical user group (first phase): Intermediate average 72.2% (95% CI 70.0–75.6%)
  • LUS interpretation accuracy by clinical user group (first phase): Advanced average 73.4% (95% CI 62.2–87.8%)
  • LUS interpretation accuracy by clinical user group (first phase): Experts average 95.0% (95% CI 88.2–100.0%)

Original publication

Clinical benefit of AI-assisted lung ultrasound in a resource-limited intensive care unit. Crit Care. Published 1 July 2023. doi:10.1186/s13054-023-04548-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.